Strengths
Small molecule API development and validation. Cost effective methods for API production as well as the sourcing and supply of API.
Strong product formulation development, not only reverse engineering reference drug products, but producing new formulations more suited the local conditions.
The active ingredient, all though essential, is not the entire process of producing a safe and effective drug. We study the pharmacokinetic profile of the originator drug. Our drug release profiles and bioavailability are intended to be as similar to the originator drug as possible.
Understanding manufacturing. We can help optimized for small batch size allowing for more efficient production. We can also tailor formulations for existing plant layouts or help in sourcing production equipment to produce drugs that have specific production requirements.
Documentation: SOPs, record systems, validation documentation are all essential parts of a robust quality system. The documentation process can be a barrier to developing new products as more robust quality standards are implemented. We have a strong knowledge base to assist manufacturers achieve full compliance.
Improving knowledge and technical competence, training and research: allows us to lift standards and expand capabilities. We are both emulator, and an innovator.
We stand on the shoulder of the giants, those who have discovered and brought to market new medicines. We use a solid depth of knowledge as the key for delivering quality pharmaceutical products to the one billion least wealthy people who live in the world's LDCs.
The formulation of drugs for LDC markets can benefit from the understanding of drug decomposition higher than standard temperatures. Using packaging and formulation improvements it can be possible to reduce the rate of drug composition to produce a drug formulation more suited to local conditions.
Strong product formulation development, not only reverse engineering reference drug products, but producing new formulations more suited the local conditions.
The active ingredient, all though essential, is not the entire process of producing a safe and effective drug. We study the pharmacokinetic profile of the originator drug. Our drug release profiles and bioavailability are intended to be as similar to the originator drug as possible.
Understanding manufacturing. We can help optimized for small batch size allowing for more efficient production. We can also tailor formulations for existing plant layouts or help in sourcing production equipment to produce drugs that have specific production requirements.
Documentation: SOPs, record systems, validation documentation are all essential parts of a robust quality system. The documentation process can be a barrier to developing new products as more robust quality standards are implemented. We have a strong knowledge base to assist manufacturers achieve full compliance.
Improving knowledge and technical competence, training and research: allows us to lift standards and expand capabilities. We are both emulator, and an innovator.
We stand on the shoulder of the giants, those who have discovered and brought to market new medicines. We use a solid depth of knowledge as the key for delivering quality pharmaceutical products to the one billion least wealthy people who live in the world's LDCs.
The formulation of drugs for LDC markets can benefit from the understanding of drug decomposition higher than standard temperatures. Using packaging and formulation improvements it can be possible to reduce the rate of drug composition to produce a drug formulation more suited to local conditions.
